
Conference Coverage
Latest Content

Low Risk of Severe COVID-19 in Vaccinated Patients With MS

FDA Expands Secukinumab Approval to Patients 12 Years and Older With Hidradenitis Suppurativa

Lebrikizumab Pediatric Data Could Expand AD Treatment Access

Long-Term Safety of Vutrisiran Confirmed in ATTR Amyloidosis Analysis

FAQs About New Legislation on PBM Reform, How It Affects Patients

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

Galleri trial data show liquid biopsy multicancer early detection tests may cut stage IV diagnoses, despite the missed primary end point.

Reproductive health conditions raise child desire but lower pregnancy intentions, spotlighting infertility gaps in women’s health and urging proactive counseling and coverage reform.

The website officially launched on February 5, introducing a key part of the Trump administration’s health care plan.

New studies link abortion bans to higher births and WIC demand and spotlight care-access gaps, cancer disparities, and value-based reforms shaping 2026.

The mental health burden of vitiligo closely resembles atopic dermatitis but differs significantly from psoriasis, a study suggests.

GPT-4o reliably scored alopecia areata severity from scalp images, showing strong concordance with experienced dermatology providers without prior AI training.

Deupirfenidone received orphan drug designation from the FDA and European Commission for idiopathic pulmonary fibrosis treatment.

Integrating behavioral health into primary care is cost-effective from the US health system perspective, with reduced prescription drug expenses being a key driver of these savings.

The findings bolster the case for using Bruton tyrosine kinase inhibitors in the treatment of Richter syndrome.











































































